Georgia Eye Partners Surgeon Among First in U.S. to Trial Breakthrough Glaucoma Technology
Dr. Gagan Sawhney of Georgia Eye Partners recently joined an elite group of ophthalmologists as one of the first five surgeons in the nation to trial the newly FDA-cleared VIA360™ Surgical System from New World Medical. This cutting-edge technology, unveiled in February 2025, represents a significant advancement in glaucoma surgery—bringing greater precision and control to…
Read More
Dr. Singer is in the news: Phase 4 PALADIN Study with ILUVIEN® Published in Peer-Reviewed Journal Ophthalmology
Phase 4 PALADIN Study with ILUVIEN® Published in Peer-Reviewed Journal Ophthalmology https://feeds.issuerdirect.com/news-release.html?newsid=5040948030919936 Read the press release authored by Dr. Singer of Medical Center of Ophthalmology. Our doctors are leading the way in innovation in our industry, thank you, Dr. Singer!
Read More
EyeSouth Partners Unveils Clinical Research Division To Further Ophthalmological Advancements
Nation’s largest surgically-focused ophthalmology network reinforces its commitment to implementing the latest eyecare advancements ATLANTA – (July 2, 2024) – EyeSouth Partners (“EyeSouth” or the “Company”) is proud to announce the expansion of its dedicated Clinical Research Division. This strategic move highlights EyeSouth’s commitment to advancing ophthalmic treatments and enhancing patient care for people throughout…
Read More
Georgia Eye Partners Becomes One of the First Practices in the United States To Offer New EVO Visian ICL Procedure
Georgia Eye Partners is proud to announce an expansion of its services to include EVO Visian® ICL, an innovative technology recently approved by the FDA, which corrects nearsightedness without the use of glasses or contact lenses. Doctors Andrew Feinberg and Evan D. Schoenberg at Georgia Eye Partners are pleased to be two of the first select doctors throughout the…
Read More